Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Rheum4U: Development and testing of a web-based tool for improving the quality of care for patients with rheumatoid arthritis.

Barber CEH, Sandhu N, Rankin JA, MacMullan P, Marshall DA, Barnabe C, Hazlewood GS, Emrick A, Stevenson M, Then KL, Benseler S, Twilt M, Mosher D.

Clin Exp Rheumatol. 2018 Aug 29. [Epub ahead of print]

PMID:
30183602
2.

Management of Temporomandibular Joint Arthritis in JIA: Tradition-based or Evidence-based?

Stoustrup P, Twilt M, Resnick CM.

J Rheumatol. 2018 Aug;45(9):1205-1207. doi: 10.3899/jrheum.180363. No abstract available.

PMID:
30173177
3.

Presentation and disease course of childhood- versus adult-onset Takayasu Arteritis.

Aeschlimann FA, Barra L, Alsolaimani R, Benseler SM, Hebert D, Khalidi N, Laxer RM, Noone D, Pagnoux C, Twilt M, Yeung RS.

Arthritis Rheumatol. 2018 Aug 12. doi: 10.1002/art.40690. [Epub ahead of print]

PMID:
30101446
4.

Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: a two-year prospective observational study.

Rahimi H, Twilt M, Herlin T, Spiegel L, Pedersen TK, Küseler A, Stoustrup P.

Pediatr Rheumatol Online J. 2018 Jul 13;16(1):47. doi: 10.1186/s12969-018-0259-4.

5.

Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care.

Barber CEH, Thorne JC, Ahluwalia V, Burt J, Lacaille D, Marshall DA, Hazlewood GS, Mosher D, Denning L, Szamko I, Chin R, Hamilton S, Benseler S, Twilt M, Shiff NJ, Bykerk V, Homik J, Barnabe C.

J Rheumatol. 2018 Nov;45(11):1501-1508. doi: 10.3899/jrheum.171284. Epub 2018 Jun 15.

PMID:
29907674
6.

Time to Reconsider Management of the Temporomandibular Joint in Juvenile Idiopathic Arthritis.

Resnick CM, Pedersen TK, Abramowicz S, Twilt M, Stoustrup PB.

J Oral Maxillofac Surg. 2018 Jun;76(6):1145-1146. doi: 10.1016/j.joms.2018.02.019. Epub 2018 Feb 26.

PMID:
29567437
7.

No association between types of unilateral mandibular condylar abnormalities and facial asymmetry in orthopedic-treated patients with juvenile idiopathic arthritis.

Stoustrup PB, Ahlefeldt-Laurvig-Lehn N, Kristensen KD, Arvidsson LZ, Twilt M, Cattaneo PM, Küseler A, Christensen AE, Herlin T, Pedersen TK.

Am J Orthod Dentofacial Orthop. 2018 Feb;153(2):214-223. doi: 10.1016/j.ajodo.2017.05.037.

PMID:
29407498
8.

Childhood Takayasu arteritis: disease course and response to therapy.

Aeschlimann FA, Eng SWM, Sheikh S, Laxer RM, Hebert D, Noone D, Twilt M, Pagnoux C, Benseler SM, Yeung RSM.

Arthritis Res Ther. 2017 Nov 22;19(1):255. doi: 10.1186/s13075-017-1452-4.

9.

Clinical Outcome and Long-term Remission in JIA.

Glerup M, Herlin T, Twilt M.

Curr Rheumatol Rep. 2017 Nov 4;19(12):75. doi: 10.1007/s11926-017-0702-4. Review.

PMID:
29101579
10.

Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis.

Hügle B, Spiegel L, Hotte J, Wiens S, Herlin T, Cron RQ, Stoll ML, Vinod S, Stoustrup P, Pedersen TK, Twilt M.

J Rheumatol. 2017 Nov;44(11):1632-1635. doi: 10.3899/jrheum.170263. Epub 2017 Sep 1.

PMID:
28864647
11.

Toward Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.

Tolend MA, Twilt M, Cron RQ, Tzaribachev N, Guleria S, von Kalle T, Koos B, Miller E, Stimec J, Vaid Y, Larheim TA, Herlin T, Spiegel L, Inarejos Clemente EJ, Moineddin R, van Rossum MA, Saurenmann RK, Doria AS, Kellenberger CJ.

Arthritis Care Res (Hoboken). 2018 May;70(5):758-767. doi: 10.1002/acr.23340. Epub 2018 Apr 12.

12.

Joint cartilage thickness and automated determination of bone age and bone health in juvenile idiopathic arthritis.

Twilt M, Pradsgaard D, Spannow AH, Horlyck A, Heuck C, Herlin T.

Pediatr Rheumatol Online J. 2017 Aug 10;15(1):63. doi: 10.1186/s12969-017-0194-9.

13.

Variations in the clinical practice of physicians managing Takayasu arteritis: a nationwide survey.

Barra L, Liang P, Benseler SM, Cabral DA, Fifi-Mah A, Li Y, Milman N, Twilt M, Yacyshyn E, Pagnoux C.

Open Access Rheumatol. 2017 May 5;9:91-99. doi: 10.2147/OARRR.S132080. eCollection 2017.

14.

Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RSM, Toth MB, Shenoi S, Ristic G, Nielsen SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; ARChiVe Investigators Network within the PedVas Initiative.

Arthritis Rheumatol. 2017 Jul;69(7):1470-1479. doi: 10.1002/art.40112. Epub 2017 Jun 9.

15.

Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.

Glerup M, Herlin T, Twilt M.

Clin Rheumatol. 2017 Mar;36(3):671-676. doi: 10.1007/s10067-017-3540-x. Epub 2017 Jan 17.

PMID:
28097448
16.

Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies.

Stoustrup P, Twilt M, Spiegel L, Kristensen KD, Koos B, Pedersen TK, Küseler A, Cron RQ, Abramowicz S, Verna C, Peltomäki T, Alstergren P, Petty R, Ringold S, Nørholt SE, Saurenmann RK, Herlin T; euroTMjoint Research Network.

J Rheumatol. 2017 Mar;44(3):326-333. doi: 10.3899/jrheum.160796. Epub 2017 Jan 15. Review.

PMID:
28089967
17.

[Primary central nervous system vasculitis in children].

Twilt M, Herlin T.

Ugeskr Laeger. 2016 Oct 17;178(42). pii: V02160155. Danish.

PMID:
27745577
18.

Accelerometer-assessed daily physical activity in relation to pain cognition in juvenile idiopathic arthritis.

Nørgaard M, Lomholt JJ, Thastum M, Herlin M, Twilt M, Herlin T.

Scand J Rheumatol. 2017 Jan;46(1):22-26. doi: 10.3109/03009742.2016.1160146. Epub 2016 Jun 16.

PMID:
27308924
19.

Central nervous system vasculitis in adults and children.

Twilt M, Benseler SM.

Handb Clin Neurol. 2016;133:283-300. doi: 10.1016/B978-0-444-63432-0.00016-5. Review.

PMID:
27112683
20.

Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.

Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative.

Arthritis Rheumatol. 2016 Oct;68(10):2514-26. doi: 10.1002/art.39729.

21.

Precision Medicine: The new era in medicine.

Twilt M.

EBioMedicine. 2016 Feb 8;4:24-5. doi: 10.1016/j.ebiom.2016.02.009. eCollection 2016 Feb. No abstract available.

22.

Clinical predictors of temporomandibular joint arthritis in juvenile idiopathic arthritis: A systematic literature review.

Kristensen KD, Stoustrup P, Küseler A, Pedersen TK, Twilt M, Herlin T.

Semin Arthritis Rheum. 2016 Jun;45(6):717-32. doi: 10.1016/j.semarthrit.2015.11.006. Epub 2015 Nov 22. Review.

PMID:
26708936
23.

CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summary.

McGeoch L, Twilt M, Famorca L, Bakowsky V, Barra L, Benseler S, Cabral DA, Carette S, Cox GP, Dhindsa N, Dipchand C, Fifi-Mah A, Goulet M, Khalidi N, Khraishi MM, Liang P, Milman N, Pineau CA, Reich H, Samadi N, Shojania K, Taylor-Gjevre R, Towheed TE, Trudeau J, Walsh M, Yacyshyn E, Pagnoux C; Canadian Vasculitis research network (CanVasc).

Can J Kidney Health Dis. 2015 Nov 9;2:43. doi: 10.1186/s40697-015-0078-1. eCollection 2015. Review.

24.

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides.

McGeoch L, Twilt M, Famorca L, Bakowsky V, Barra L, Benseler SM, Cabral DA, Carette S, Cox GP, Dhindsa N, Dipchand CS, Fifi-Mah A, Goulet M, Khalidi N, Khraishi MM, Liang P, Milman N, Pineau CA, Reich HN, Samadi N, Shojania K, Taylor-Gjevre R, Towheed TE, Trudeau J, Walsh M, Yacyshyn E, Pagnoux C; Canadian Vasculitis Research Network.

J Rheumatol. 2016 Jan;43(1):97-120. doi: 10.3899/jrheum.150376. Epub 2015 Nov 1. Review.

PMID:
26523024
25.

Accelerometry-based monitoring of daily physical activity in children with juvenile idiopathic arthritis.

Nørgaard M, Twilt M, Andersen LB, Herlin T.

Scand J Rheumatol. 2016;45(3):179-87. doi: 10.3109/03009742.2015.1057862. Epub 2015 Sep 23.

PMID:
26399487
26.

Therapy. Intra-articular steroids for TMJ arthritis--caution needed.

Stoustrup P, Twilt M.

Nat Rev Rheumatol. 2015 Oct;11(10):566-7. doi: 10.1038/nrrheum.2015.97. Epub 2015 Jul 14.

PMID:
26168913
27.

Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.

Anink J, Prince FH, Dijkstra M, Otten MH, Twilt M, ten Cate R, Gorter SL, Koopman-Keemink Y, van Rossum MA, Hoppenreijs EP, van Suijlekom-Smit LW.

Rheumatology (Oxford). 2015 Nov;54(11):1964-9. doi: 10.1093/rheumatology/kev195. Epub 2015 Jun 14.

PMID:
26078219
28.

The growing spectrum of antibody-associated inflammatory brain diseases in children.

Bigi S, Hladio M, Twilt M, Dalmau J, Benseler SM.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 2;2(3):e92. doi: 10.1212/NXI.0000000000000092. eCollection 2015 Jun.

29.

Development of Canadian Recommendations for the Management of ANCA-Associated Vasculitides: Results of the National Needs Assessment Questionnaire.

Famorca L, Twilt M, Barra L, Bakowsky V, Benseler S, Cabral D, Carette S, Dhindsa N, Fifi-Mah A, Goulet M, Khalidi N, Khraishi M, McGeoch L, Milman N, Pineau C, Shojania K, Taylor-Gjevre R, Towheed T, Trudeau J, Yacyshyn E, Liang P, Pagnoux C; Canadian Vasculitis network (CanVasc).

Open Rheumatol J. 2015 Apr 14;9:16-20. doi: 10.2174/18743129014090100016. eCollection 2015.

30.

Mutations in CECR1 associated with a neutrophil signature in peripheral blood.

Belot A, Wassmer E, Twilt M, Lega JC, Zeef LA, Oojageer A, Kasher PR, Mathieu AL, Malcus C, Demaret J, Fabien N, Collardeau-Frachon S, Mechtouff L, Derex L, Walzer T, Rice GI, Durieu I, Crow YJ.

Pediatr Rheumatol Online J. 2014 Sep 24;12:44. doi: 10.1186/1546-0096-12-44. eCollection 2014.

31.

The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood.

Noone DG, Twilt M, Hayes WN, Thorner PS, Benseler S, Laxer RM, Parekh RS, Hebert D.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1684-91. doi: 10.2215/CJN.01210214. Epub 2014 Aug 21.

32.

Reliability of clinical symptoms in diagnosing temporomandibular joint arthritis in juvenile idiopathic arthritis.

Koos B, Twilt M, Kyank U, Fischer-Brandies H, Gassling V, Tzaribachev N.

J Rheumatol. 2014 Sep;41(9):1871-7. doi: 10.3899/jrheum.131337. Epub 2014 Jul 1.

PMID:
24986847
33.

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.

Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, Muscal E, Deiva K, Andersen E, Eyre MR, Eleftheriou D, Brogan PA, Kneen R, Alper G, Anlar B, Wassmer E, Heineman K, Hemingway C, Riney CJ, Kornberg A, Tardieu M, Stocco A, Banwell B, Gorman MP, Benseler SM, Lim M.

Neurology. 2014 Jul 8;83(2):142-50. doi: 10.1212/WNL.0000000000000570. Epub 2014 Jun 11.

34.

Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.

Otten MH, Anink J, Prince FH, Twilt M, Vastert SJ, ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.

Ann Rheum Dis. 2015 Jul;74(7):1379-86. doi: 10.1136/annrheumdis-2013-204641. Epub 2014 Mar 18.

PMID:
24641940
35.

Distinct phenotype clusters in childhood inflammatory brain diseases: implications for diagnostic evaluation.

Cellucci T, Tyrrell PN, Twilt M, Sheikh S, Benseler SM.

Arthritis Rheumatol. 2014 Mar;66(3):750-6. doi: 10.1002/art.38274.

36.

Juvenile idiopathic arthritis of the axial joints: a systematic review of the diagnostic accuracy and predictive value of conventional MRI.

Munir S, Patil K, Miller E, Uleryk E, Twilt M, Spiegel L, Doria AS.

AJR Am J Roentgenol. 2014 Jan;202(1):199-210. doi: 10.2214/AJR.12.10475. Review.

PMID:
24370145
37.

Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy.

Twilt M, Benseler SM.

Rheumatology (Oxford). 2014 Aug;53(8):1359-68. doi: 10.1093/rheumatology/ket398. Epub 2013 Dec 9. Review.

PMID:
24324213
38.

Childhood antineutrophil cytoplasmic antibodies associated vasculitides.

Twilt M, Benseler S.

Curr Opin Rheumatol. 2014 Jan;26(1):50-5. doi: 10.1097/BOR.0000000000000013. Review.

PMID:
24247117
39.

CNS vasculitis in children.

Twilt M, Benseler SM.

Mult Scler Relat Disord. 2013 Jul;2(3):162-71. doi: 10.1016/j.msard.2012.11.002. Epub 2013 Jan 10. Review.

PMID:
25877722
40.

Primary and secondary central nervous system vasculitis.

Gowdie P, Twilt M, Benseler SM.

J Child Neurol. 2012 Nov;27(11):1448-59. doi: 10.1177/0883073812459352. Epub 2012 Sep 24. Review.

PMID:
23006496
41.

Granulomatosis with polyangiitis in childhood.

Twilt M, Benseler S, Cabral D.

Curr Rheumatol Rep. 2012 Apr;14(2):107-115. doi: 10.1007/s11926-012-0238-6. Review.

PMID:
22286604
42.

The spectrum of CNS vasculitis in children and adults.

Twilt M, Benseler SM.

Nat Rev Rheumatol. 2011 Dec 20;8(2):97-107. doi: 10.1038/nrrheum.2011.197. Review.

PMID:
22183571
43.

Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.

Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, Koopman-Keemink Y, Gorter SL, Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW.

JAMA. 2011 Dec 7;306(21):2340-7. doi: 10.1001/jama.2011.1671. Epub 2011 Nov 6.

PMID:
22056397
44.

Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.

Otten MH, Prince FH, Twilt M, Ten Cate R, Armbrust W, Hoppenreijs EP, Koopman-Keemink Y, Wulffraat NM, Gorter SL, Dolman KM, Swart JF, van den Berg JM, van Rossum MA, van Suijlekom-Smit LW.

J Rheumatol. 2011 Oct;38(10):2258-63. doi: 10.3899/jrheum.110145. Epub 2011 Aug 15.

PMID:
21844151
45.

Clinical care of children with sterile bone inflammation.

Twilt M, Laxer RM.

Curr Opin Rheumatol. 2011 Sep;23(5):424-31. doi: 10.1097/BOR.0b013e328349c363. Review.

PMID:
21788901
46.

An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register.

Prince FH, de Bekker-Grob EW, Twilt M, van Rossum MA, Hoppenreijs EP, ten Cate R, Koopman-Keemink Y, Gorter SL, Raat H, van Suijlekom-Smit LW.

Rheumatology (Oxford). 2011 Jun;50(6):1131-6. doi: 10.1093/rheumatology/keq432. Epub 2011 Jan 27.

PMID:
21278067
47.

Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?

Otten MH, Prince FH, Ten Cate R, van Rossum MA, Twilt M, Hoppenreijs EP, Koopman-Keemink Y, Oranje AP, de Waard-van der Spek FB, Gorter SL, Armbrust W, Dolman KM, Wulffraat NM, van Suijlekom-Smit LW.

Ann Rheum Dis. 2011 Feb;70(2):337-40. doi: 10.1136/ard.2010.135731. Epub 2010 Nov 10.

PMID:
21068101
48.

Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanercept.

Otten MH, Prince FH, Twilt M, van Rossum MA, Armbrust W, Hoppenreijs EP, Kamphuis S, Koopman-Keemink Y, Wulffraat NM, Gorter SL, Ten Cate R, van Suijlekom-Smit LW.

J Rheumatol. 2010 Mar;37(3):665-7. doi: 10.3899/jrheum.090550. Epub 2010 Jan 15.

PMID:
20080910
49.

Long-term follow-up of craniofacial alterations in juvenile idiopathic arthritis.

Twilt M, Schulten AJ, Prahl-Andersen B, van Suijlekom-Smit LW.

Angle Orthod. 2009 Nov;79(6):1057-62. doi: 10.2319/093008-511R.1.

PMID:
19852594
50.

Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.

Prince FH, Geerdink LM, Borsboom GJ, Twilt M, van Rossum MA, Hoppenreijs EP, Cate RT, Koopman-Keemink Y, van Santen-Hoeufft M, Raat H, van Suijlekom-Smit LW.

Ann Rheum Dis. 2010 Jan;69(1):138-42. doi: 10.1136/ard.2009.111260.

PMID:
19581280

Supplemental Content

Support Center